About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

BostonGene Named Platinum Winner for AI Research Innovation at 2025 Pinnacle Awards

AI-powered multiomic platform honored for driving discovery, patient stratification and clinical trial optimization

BostonGene, a leader in AI-powered solutions for drug discovery and development, has won Platinum in the AI Research Innovation category at the 2025 Pinnacle Awards. This recognition underscores BostonGene’s pivotal role in transforming multiomic data into actionable insights that drive smarter trial design, enable patient stratification and accelerate development timeliness--helping bring therapies to patients faster.

“We’re proud to receive this award, which highlights the impact of our platform in advancing therapeutic development,” said Alexander Bagaev, PhD, Chief Product Officer at BostonGene. “By integrating AI, multiomic profiling and real-world evidence, we enable drug developers to make smarter decisions—identifying responder populations, de-risking pipelines and shortening trial timelines. The result is a faster path to life-changing treatments for patients.”

AI-Powered Innovation Driving Therapeutic Success

BostonGene’s platform integrates genomic, transcriptomic, immune and spatial profiling—including whole exome and transcriptome sequencing, liquid biopsy, flow cytometry and spatial proteomics—delivering a comprehensive, multidimensional view of disease biology.

With this integrated view, the platform enables:

  • Discovering predictive biomarkers to guide precision trial design
  • Improving patient stratification to increase response rates
  • Assessing adverse event risk to strengthen safety
  • Optimizing trial endpoints and inclusion criteria to accelerate development

Breaking Through Traditional Limitations

Unlike conventional approaches that rely on static, single-gene markers, BostonGene’s proprietary AI models—trained on large-scale, real-world datasets—capture the full complexity of the tumor and immune microenvironment.

These models enable:

  • Predicting treatment response with greater accuracy
  • Identifying resistance mechanisms earlier
  • Reducing late-stage clinical trial failures

By providing decision-ready evidence from discovery through pivotal trials, BostonGene empowers drug developers to optimize trial design, prioritize assets with confidence, minimize R&D risk and accelerate commercialization.

The Pinnacle Awards celebrate innovation and excellence in technology across industries. Judged by a panel of industry experts, the program honors organizations delivering measurable impact through breakthrough solutions that set new standards in their fields.

About BostonGene Corporation

BostonGene helps drug developers de-risk and accelerate research and development using a clinically validated AI platform purpose-built for oncology and supported by a CLIA-certified and CAP-accredited clinical laboratory. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights that inform trial design, optimize patient selection and improve clinical outcomes. Our diagnostic and treatment recommendation solutions are used in clinical settings to personalize care and guide therapy decisions for patients. For more information, visit www.BostonGene.com.

By integrating AI, multiomic profiling and real-world evidence, we enable drug developers to make smarter decisions—identifying responder populations, de-risking pipelines and shortening trial timelines.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.